NTRA241220P120000
- 0.05
- 0.000.00%
Natera Newsroom
Express News | Natera Inc : Leerink Partners Raises Target Price to $200 From $185
Natera and MyOme Announce Launch of IPRS for Breast Cancer Risk Assessment
Natera Aligns Executive Chairman's Pay With Performance
Natera(NTRA.US) Director Sells US$14.79 Million in Common Stock
Natera Insider Sold Shares Worth $14,793,563, According to a Recent SEC Filing
Insider Sale: Director at $NTRA (NTRA) Sells 40,171 Shares
Strong Volume Growth Lifted Natera (NTRA) in Q3
Express News | Form 144 | Natera(NTRA.US) Director Proposes to Sell 14.79 Million in Common Stocks
Why Is Natera, Inc. (NTRA) Among the Best High Growth Healthcare Stocks to Invest In Now?
Looking Into Natera's Recent Short Interest
Clinical Validation Study on Natera's Fetal RhD NIPT Published in Obstetrics & Gynecology
Natera, Inc.'s (NASDAQ:NTRA) 32% Price Boost Is Out Of Tune With Revenues
Insider Sale: EXECUTIVE CHAIRMAN of $NTRA (NTRA) Sells 400 Shares
Express News | Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients
Piper Sandler Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $200
Piper Sandler Sticks to Their Buy Rating for Natera (NTRA)
Trade Alert: Independent Director Of Natera Gail Marcus Has Sold Stock
Express News | Guardant Health Says Jury Unanimously Rejected All Of Natera's Counterclaims And Awarded $292.5M To Company, Including $175.5M In Punitive Damages
Express News | Guardant Health Shares Are Trading Higher After a Jury Issued a Decision in the Company's Favor Regarding a False Advertising Case Filed by Natera Concerning Statements Made About Guardant's Reveal Test
Natera Issues Statement On Guardant Health Litigation; Says "A Jury Issued A Decision In Guardant's Favor. We Disagree With This Decision And Will Ask The Court To Overturn It"